Health ❯ Healthcare ❯ Pharmaceuticals ❯ Regulatory Affairs

FDA

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

The update follows overseas safety actions and arrives as Pfizer confronts lawsuits from more than 1,000 women over alleged failures to warn.

FDA Proposes Adding Bemotrizinol to U.S. Sunscreens, Invites Public Comment

Vinay Prasad Resigns as FDA Biologics Director After Politicized Tenure